2023-05-01 2024-04-30 false Capium Accounts Production 1.1 11961684 2023-05-01 2024-04-30 11961684 bus:AbridgedAccounts 2023-05-01 2024-04-30 11961684 bus:FRS102 2023-05-01 2024-04-30 11961684 bus:AuditExemptWithAccountantsReport 2023-05-01 2024-04-30 11961684 bus:SmallCompaniesRegimeForAccounts 2023-05-01 2024-04-30 11961684 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 11961684 2023-05-01 2024-04-30 11961684 2024-04-30 11961684 bus:RegisteredOffice 2023-05-01 2024-04-30 11961684 core:WithinOneYear 2024-04-30 11961684 core:AfterOneYear 2024-04-30 11961684 1 2023-05-01 2024-04-30 11961684 bus:Director1 2023-05-01 2024-04-30 11961684 bus:Director1 2024-04-30 11961684 bus:Director1 2022-05-01 2023-04-30 11961684 2022-05-01 11961684 bus:LeadAgentIfApplicable 2023-05-01 2024-04-30 11961684 2022-05-01 2023-04-30 11961684 2023-04-30 11961684 core:WithinOneYear 2023-04-30 11961684 core:AfterOneYear 2023-04-30 11961684 bus:EntityAccountantsOrAuditors 2022-05-01 2023-04-30 11961684 core:NetGoodwill 2023-05-01 2024-04-30 11961684 core:NetGoodwill 2024-04-30 11961684 core:NetGoodwill 2023-04-30 11961684 core:CostValuation core:Non-currentFinancialInstruments 2024-04-30 11961684 core:CostValuation core:Non-currentFinancialInstruments 2023-04-30 11961684 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-04-30 11961684 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-04-30 11961684 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-04-30 11961684 core:Non-currentFinancialInstruments 2024-04-30 11961684 core:Non-currentFinancialInstruments 2023-04-30 11961684 core:ShareCapital 2024-04-30 11961684 core:ShareCapital 2023-04-30 11961684 core:RetainedEarningsAccumulatedLosses 2024-04-30 11961684 core:RetainedEarningsAccumulatedLosses 2023-04-30 11961684 dpl:Item1 2023-05-01 11961684 dpl:Item1 2024-04-30 11961684 dpl:Item1 2022-05-01 11961684 dpl:Item1 2023-04-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 11961684
England and Wales

 

 

 

WYE VALLEY PHARMA LTD


Abridged Accounts
 


Period of accounts

Start date: 01 May 2023

End date: 30 April 2024
Accountant’s report
You consider that the company is exempt from an audit for the year ended 30 April 2024 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts.
Myrtle Gund Ltd
30 April 2024



....................................................

Myrtle Gund Ltd

248 Lockwood Road

Huddersfield
HD1 3TG
25 April 2025
1
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Intangible fixed assets 3 280,000    297,500 
280,000    297,500 
Current assets      
Stocks 40,563    40,563 
Debtors 723,856    195,325 
Cash at bank and in hand 395,964    559,702 
1,160,383    795,590 
Creditors: amount falling due within one year (849,814)   (513,614)
Net current assets 310,569    281,976 
 
Total assets less current liabilities 590,569    579,476 
Creditors: amount falling due after more than one year (347,255)   (336,616)
Net assets 243,314    242,860 
 

Capital and reserves
     
Called up share capital 100    100 
Profit and loss account 243,214    242,760 
Shareholders' funds 243,314    242,860 
 


For the year ended 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 25 April 2025 and were signed by:


-------------------------------
Etisham Kiani
Director
2
General Information
WYE VALLEY PHARMA LTD is a private company, limited by shares, registered in England and Wales, registration number 11961684, registration address 111 Main Road, Middleton, OX17 2PD.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Intangible assets
Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.
Goodwill
Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of 20 years.
Stocks
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
2.

Average number of employees

Average number of employees during the year was 6 (2023 : 6).
3.

Intangible fixed assets

Cost Goodwill   Total
  £   £
At 01 May 2023 350,000    350,000 
Additions  
Disposals  
At 30 April 2024 350,000    350,000 
Amortisation
At 01 May 2023 52,500    52,500 
Charge for year 17,500    17,500 
On disposals  
At 30 April 2024 70,000    70,000 
Net book values
At 30 April 2024 280,000    280,000 
At 30 April 2023 297,500    297,500 


3